Combining Radiotherapy and Immunotherapy in Head and Neck Cancer

Combining Radiotherapy and Immunotherapy in Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a leading cause of morbidity and mortality globally. Despite significant advances in well-established treatment techniques, prognosis for advanced-stage HNSCC remains poor. Recent, accumulating evidence supports a role for immunotherapy in HNSCC treat...

Full description

Bibliographic Details
Main Authors: Juliana Runnels, Julie R. Bloom, Kristin Hsieh, Daniel R. Dickstein, Yuhao Shi, Brianna M. Jones, Eric J. Lehrer, Richard L. Bakst
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
immunotherapy
radiation therapy
head and neck cancer squamous cell cancer
Online Access:https://www.mdpi.com/2227-9059/11/8/2097

Internet

https://www.mdpi.com/2227-9059/11/8/2097

Similar Items